CD63 and neoplasm: Under experimental conditions in which control and CD63-Antares2-expressing cells showed the same tumor growth (Fig. 2b), the bioluminescence intensity in the blood gradually increased with increasing PC3/CD63-Antares2 tumor size (Fig. 2c).